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A bromoperoxidase could be detected after fractionation in the chloramphenicol producing actinomycete, 
Streptomyces phaeochromogenes. This enzyme is capable of catalyzing the bromination of the antifungal 
antibiotic pyrrolnitrin [3-chloro-4-(2-nitro-3-chlorophenyl)pyrrole] in the 2-position of the pyrrole ring. 
The enzyme had a pH optimum of 5.0. This procaryotic bromoperoxidase requires the presence of Hz02 
and can also brominate monochlorodimedone, but cannot catalyze chlorination. This enzyme is the first 
haloperoxidase described from procaryotic sources. 
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1. INTRODUCTION 
Among many microbial natural halometabolites 
a few bromo derivatives such as bromonitrins 
[ 1,2], pyrrolomycins [3] and bromo analogues of 
chloramphenicol [4] are known. The enzymatic in- 
corporation of chlorine into organic metabolites is 
known to be catalyzed by myeloperoxidase [5] and 
by chloroperoxidase from Caldariomyces fumago 
[a]. Bromoperoxidases, enzymes that in the 
presence of hydrogen peroxidase oxidize Br- but 
not Cl-, were isolated from several marine algae 
[7-91, but to date no enzyme capable of chlorina- 
tion or bromination has been discovered in 
bacteria. 
Here we describe the bromination of pyr- 
rolnitrin (form I) by an enzyme from Streptomyces 
phaeochromogenes, a chloramphenicol producing 
actinomycete. The bromination of pyrrolnitrin was 
used to confirm the nature of the reaction. 
2. MATERIALS AND METHODS 
2.1. Chemicals 
Pyrrolnitrin was a gift of Ciba-Geigy (Basel, 
Switzerland). Hz02 (30%) was purchased from 
Merck (Darmstadt, FRG). Monochlorodimedone 
was prepared from dimedone by chlorination with 
sodium hypochloride [lo]. Protamine sulfate 
(salmine-sulfate) was purchased from Fluka 
(Buchs, Switzerland). 
2.2. Organism and culture conditions 
S. phaeochromogenes NRRL B-3559 was re- 
ceived from Northern Regional Research Labora- 
tories (Peoria, IL). This chloramphenicol pro- 
ducing strain was grown in 2-l Erlenmeyer flasks, 
containing 1 1 medium at 30°C for 96 h on a rotary 
shaker. The mineral salt medium described [l 11, 
with glucose as the carbon source and L-isoleucine 
as the nitrogen source, was used. Cells were 
harvested by centrifugation, yielding about 12 g/l 
(wet wt). 
2.3. Enzyme assays 
Brominating activity was measured as in [12] 
with monochlorodimedone (44 PM) as substrate in 
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the’ presence of Hz02 (7.2 mM) and bromide 
(82 mM) and a suitable amount of enzyme in 
0.1 M sodium acetate buffer (pH 5.5). The reac- 
tion was started by the addition of H202. The 
decrease in monochlorodimedone absorbance at 
290 nm (6 = 1.99 x lo4 M-’ - cm-‘) with time was 
recorded on a Uvikon 810 spectrophotometer 
(Kontron). One unit of bromoperoxidase activity 
was defined as the formation of 1 pmol mono- 
bromomonochlorodimedone/min. Pyrrolnitrin 
was brominated in a 110 ml assay containing pyr- 
rolnitrin (22.9pM), sodium bromide (82 mM), 
Hz02 (72 mM), and 35.8 munits crude bromo- 
peroxidase in 0.1 M sodium acetate buffer (pH 
5.5). The reaction was started by the addition of 
H202. After incubation for 30 min at 25”C, 
another 35.8 munits of crude bromoperoxidase 
were added and the incubation was continued for 
a further 30 min. 
2.4. Isolation and purification of brominated 
pyrrolnitrin 
The reaction mixture was extracted twice with 
2 vols ethyl acetate. The combined extracts were 
dried over anhydrous MgS04 and evaporated to 
dryness. The residue was dissolved in as little 
methanol-water (70: 30, v/v) as possible, and 
purified by high-performance liquid chromatog- 
raphy (HPLC). The HPLC separations were per- 
formed on an HPLC apparatus (Knauer, Berlin, 
FRG) equipped with a dual detector and stainless 
steel columns (8 x 250 mm) filled with LiChrosorb 
RP8 (5-20pm). The solvent system was metha- 
nol-water (70: 30, v/v). A flow rate of 2 ml/min 
was maintained and the effluent was monitored at 
254 nm. 
2.5. Spectral characterisation 
UV, spectrophotometer Uvikon 810 (Kontron, 
FRG); GC-MS, mass-spectrometer Varian 3700 
(Varian, Bremen, FRG); glass capillary column, 
25 m, SE 30; ‘H-NMR, Bruker WM 250 (Bruker, 
Karlsruhe-Forchheim, FRG). 
2.6. Partial purification of bromoperoxidase 
One part of cells (wet wt) was suspended in two 
parts of 50 mM sodium acetate buffer (pH 5.5) 
and disrupted with a Branson sonifier J-17 A for 
six 30-s periods. The cell debris was removed by 
centrifugation for 30 min at 22100 x g and 4°C. 
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To the crude extract, protamine sulfate was added 
to 0.2% and the mixture was stirred for 20 min. 
The precipitate was removed by centrifugation for 
30 min at 22 100 x g. The supernatant was brought 
to 35% saturation with solid (NH&S04. After 
stirring for 30 min the precipitate was removed by 
centrifugation and the supernatant was brought to 
70% saturation with solid (NH4)2S04. After 
stirring for 30 min the precipitate was collected by 
centrifugation and was dissolved in 50 mM sodium 
acetate buffer (pH 5.5) and dialyzed for 15 h 
against 5 1 of the same buffer. The solution was 
passed onto a column (10.0 x 2.7 cm) of DE 52 
and equilibrated with 50 mM sodium acetate buf- 
fer (PH 5.5). The sample was washed onto this 
column with 450 ml of this buffer and a 1.2-I gra- 
dient (0.2-0.6 M sodium acetate buffer, pH 5.5) 
was applied. Fractions (6.4 ml) were assayed for 
protein (A280) and haloperoxidase activity. Those 
fractions (67- 115) having an activity of more than 
15% of the maximal activity were pooled and con- 
centrated using an Amicon concentrator with a 
PM-30 membrane. The concentrated, pooled frac- 
tions were dialyzed for 15 h against 5 1 of 10 mM 
potassium phosphate buffer (pH 7.0) and stored at 
- 20°C. 
3. RESULTS 
When the crude extract was used, neither 
monochlorodimedone nor pyrrolnitrin was halo- 
genated. With the supernatant of the protamine 
sulfate precipitation a negative result was obtain- 
ed, too. Using the redissolved pellet of the 35-70% 
(NH&S04 precipitation, no halogenating activity 
was detectable ither. However, when the eluate of 
the DE 52 column was tested, about two-thirds of 
the way through the salt gradient, protein, exhibi- 
ting brominating activity, was eluted. The pooled 
fractions had a specific activity of 0.12 units/mg 
for the bromination of monochlorodimedone. 
When Cl- was used instead of Br- none of the two 
organic substrates was halogenated. The addition 
of bromide and fluoride to the monochlorodimed- 
one assay at pH 5.5 resulted in partial inhibition, 
as is shown in fig. 1. The pH optimum is 5.0. At pH 
4.5 the enzyme is already totally inactive, whereas 
at pH 7.0 there is still 30% of the maximal activity 
(fig.2). 
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Fig. 1. Monochlorodimedone assay with bromoper- 
oxidase from S. phaeochromogenes. The assays were 
carried out as described insection 2. The curves compare 
the rate of bromination of monochlorodimedone (44 
PM), when the assays are initiated with Hz02 (arrows). 
Curve A shows the bromination in the presence of 
82 mM bromide and Hz02 (7.2 mM). The reactions with 
82 mM chloride (B), 82 mM bromide and 82 mM 
chloride (C) and 82 mM bromide in the presence of 
82 mM fluoride (D) at pH 5.5 are shown. 
The product of the enzymatic bromination of 
pyrrolnitrin was purified by HPLC. The elemental 
composition of the obtained compound was 
established by GC-MS. The molecular ion ap- 
peared as a quartet at m/e 334/336/338/340 (in- 
tensity ratio, 10/16/7/l). This is characteristic of 
a monobromodichloro-substituted compound. 
The UV absorption spectrum in MeOH (neutral 
and acidic 0.1 N HCl) exhibited a shoulder at 274 
and 240 nm. In alkaline solution (0.1 N NaOH) 
the spectrum showed a maximum at A,, = 274 nm 
and a shoulder at 310 nm. 
Fig.2. The effect of pH on the brominative activity of S. 
phaeochromogenes bromoperoxidase using the mono- 
chlorodimedone assay in 0.1 M potassium phosphate 
buffer. 
The detailed structure was analyzed by ‘H- 
NMR. The signal for pyrrole C-H was equivalent 
to one proton at 7.03 ppm in (CD&CO, which can 
be assigned to the 2-position; a substituent in 
5-position (ortho to the biaryl linkage) should 
strongly influence the 6’-H signal at 7.602 ppm 
(pyrrolnitrin at 7.605 ppm) [2]. From these spec- 
tral findings we deduce the structure 2-bromo-3- 
chloro-4-(2-nitro-3-chlorophenyl)pyrrole (form II). 
4. DISCUSSION 
Although several bromoperoxidases from 
marine algae [6-S] and two chlorinating enzymes 
[4,5] are already known, to date no haloperoxidase 
has been discovered in bacteria. In crude extracts 
from S. phaeochromogenes no halogenating activi- 
ty can be detected either. However, when the ex- 
tract is fractionated, using a DE 52 column with 
sodium acetate buffer (pH 5.5) the monochlorodi- 
medone test can be employed successfully. This is 
7 
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probably due to the fact that crude extracts of S. 
phaeochromogenes contain catalase which com- 
petes very efficiently with bromoperoxidase for 
HzOz. Only after sufficient removal of this cata- 
lase can halogenating activity be measured. 
Surprisingly, only brominating activity could be 
detected with monochlorodimedone as substrate. 
To check this result, we used pyrrolnitrin (form I) 
as substrate, because from our previous studies on 
pyrrolnitrin biosynthesis [2] we had some ex- 
perience on the purification and structural elucida- 
tion of pyrrolnitrin derivatives. The obtained pro- 
duct [2-bromo-3-chloro-4-(2-nitro-3-chlorophen- 
yl)pyrrole (form II)] confirmed the result, obtained 
with the monochlorodimedone test. The enriched 
enzyme was only capable of bromination although 
S. phaeochromogenes produces chloramphenicol, 
a chloride-containing metabolite. 
Whether chlorination in S. phaeochromogenes is 
bromonium ion-induced as postulated for the for- 
mation of some chlorometabolites in marine algae 
(131, or whether chlorinating activity is not detec- 
table because of a yet unknown inhibitor or 
because of an interfering enzyme is not yet known. 
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